These findings align with literature proposing multiple pathways through which semaglutide may act, mitigating vascular stiffening, adverse lipid profiles, inflammation, and endothelial dysfunction, alongside effects on glycemic control, insulin resistance, and weight loss [1, 4]
Fatal semaglutide overdose is extremely rare
Other forms, like Ozempic and Rybelsus, also contain semaglutide but they are more commonly used for blood sugar support and are not used in the same way
Preliminary evidence from the first published case report on semaglutide treatment for MC4R -deficient obesity [76] suggested a potential therapeutic effect
Low-quality dairy products can also encourage oxidative stress and inflammation
Clinical Status Human RCT | Observational | Animal | In vitro Primarily studied in preclinical and regional aging research contexts, with limited exploratory human data